| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/11/2010 | US20100061964 Method for preparing pancreatic beta cells starting from beta cell progenitors and beta cells thereby obtained |
| 03/11/2010 | US20100061961 Recombinant super-compound interferon |
| 03/11/2010 | US20100061960 Amido Anti-Viral Compounds, Compositions, And Methods Of Use |
| 03/11/2010 | US20100061959 Methods for providing neuroprotection for the animal central nervous system against the effects of ischemia, neurodegeneration, trauma, and metal poisoning |
| 03/11/2010 | US20100061958 Modulation of Regulatory T Cells by Human IL-18 |
| 03/11/2010 | US20100061957 Hpv-16-based papillomavirus vaccines |
| 03/11/2010 | US20100061942 Compositions and Methods for Modulating Store-Operated Calcium Entry |
| 03/11/2010 | US20100061935 Methods of using sustained release aminopyridine compositions |
| 03/11/2010 | US20100061932 Peptides useful as cell-penetrating peptides |
| 03/11/2010 | US20100061929 Neoplasia targeting peptides and methods of using the same |
| 03/11/2010 | DE102008046610A1 Verwendung einer pharmazeutischen Zusammensetzung zur lokalen Infektionstherapie sowie Medizinprodukt Use of a pharmaceutical composition for local infection therapy and medical device |
| 03/11/2010 | CA2739416A1 Agents and methods for treatment of pain |
| 03/11/2010 | CA2738034A1 Materials and methods for inhibiting cancer cell invasion related to fgfr4 |
| 03/11/2010 | CA2736314A1 Periostin-induced pancreatic regeneration |
| 03/11/2010 | CA2736187A1 Novel compositions and adjuvants |
| 03/11/2010 | CA2736126A1 Process for making bivalirudin |
| 03/11/2010 | CA2736113A1 Process for the preparation of pramlintide |
| 03/11/2010 | CA2735811A1 Compositions and methods for inhibiting entry of a hepatic virus |
| 03/11/2010 | CA2735465A1 Treatment of fructose-malabsorption |
| 03/11/2010 | CA2735376A1 New protecting compositions for recombinantly produced factor viii |
| 03/11/2010 | CA2735085A1 Fc gamma receptpr for the treatement of b cell mediated multiple sclerosis |
| 03/11/2010 | CA2735006A1 Pd-1 antagonists and methods of use thereof |
| 03/11/2010 | CA2733943A1 Peptides presenting an epitope of an a domain of factor h binding protein and methods of use |
| 03/11/2010 | CA2730328A1 Immunogenic escherichia coli heat stable enterotoxin |
| 03/10/2010 | EP2161578A1 Proteins in diabetes proteome analysis |
| 03/10/2010 | EP2161287A1 OPTIMIZED TACI-Fc FUSION PROTEINS |
| 03/10/2010 | EP2161286A1 Antibodies |
| 03/10/2010 | EP2161284A1 Citrulinated fibrin-filaggrin chimeric polypeptide capable of detecting the antibodies generated in rheumatoid arthritis |
| 03/10/2010 | EP2161282A1 Peptide analogues of PACAP |
| 03/10/2010 | EP2161281A1 Muteins of fibroblast growth factor 21 |
| 03/10/2010 | EP2161280A2 Genes involved in the regulation of angiogenesis, pharmaceutical preparations containing them and their applications |
| 03/10/2010 | EP2161037A2 Camptothecin-Somatostatin conjugates |
| 03/10/2010 | EP2161034A1 Treatment of fructose malabsorption |
| 03/10/2010 | EP2161033A1 A chemodenervating agent to introduce temporal infertiliy in a vertebrate (e.g. human) |
| 03/10/2010 | EP2161032A2 Methods of healing wounds by administering human IL-18 |
| 03/10/2010 | EP2161031A1 Fc gamma receptor for the treatment of B cell mediated multiple sclerosis |
| 03/10/2010 | EP2161030A1 Oxytocin formulations and uses thereof |
| 03/10/2010 | EP2161029A1 Composition comprising peptides |
| 03/10/2010 | EP2161028A1 Composition comprising peptides |
| 03/10/2010 | EP2161027A2 Diastereomeric peptides useful as inhibitors of membrane protein assembly |
| 03/10/2010 | EP2160404A1 Azapeptides as cd36 binding compounds |
| 03/10/2010 | EP2160221A1 Cyclic peptide cxcr4 antagonists |
| 03/10/2010 | EP2160196A2 Compounds for the treatment of ischemia and neurodegeneration |
| 03/10/2010 | EP1677833B1 Virus vector for use in in vivo gene therapy of Parkinson's disease |
| 03/10/2010 | EP1641474B1 Therapeutical composition containing dentritic cells and use thereof |
| 03/10/2010 | EP1605964B1 TARGETED PROTEIN DEGRADATION VEHICLES (TPDVs), NUCLEIC ACID CONSTRUCTS ENCODING THEM AND THEIR USE |
| 03/10/2010 | EP1544293B1 Antibody against enzyme specifically cleaving von villebrand factor and assay system using the same |
| 03/10/2010 | EP1483588B1 Screening method for identifying protective substances for treating neurodegenerative and/or ischemic disorders |
| 03/10/2010 | EP1114061B1 FACTOR VIIa INHIBITORS |
| 03/10/2010 | EP0932678B2 A family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
| 03/10/2010 | EP0830146B1 Methods of inducing immune tolerance using immunotoxins |
| 03/10/2010 | CN101668538A macrocyclic hepatitis c protease inhibitors |
| 03/10/2010 | CN101668537A Remedy for acute hepatitis or preventive/remedy for fulminant hepatitis |
| 03/10/2010 | CN101668536A Compositions and methods to prevent cancer with cupredoxins |
| 03/10/2010 | CN101668535A Glp-1药物组合物 Glp-1 The pharmaceutical composition of |
| 03/10/2010 | CN101665538A Novel GLP-1 analogues linked to albumin-like agents |
| 03/10/2010 | CN101665536A Anti-vegf antibodies |
| 03/10/2010 | CN101664548A Nonsurgical beauty culture by injection for bone contraction, hip contraction and weight loss |
| 03/10/2010 | CN101664547A Medicament used for treating scalds and having skin-care function |
| 03/10/2010 | CN101664546A Medicament used for treating scalds and having function of repairing skins |
| 03/10/2010 | CN101664545A Therapies for renal failure using interferon-beta |
| 03/10/2010 | CN101664544A Compound preparation for treating avian viral diseases, and preparation method thereof |
| 03/10/2010 | CN101664543A Hemokinin-iron oral liquid |
| 03/10/2010 | CN101664388A transnasal transport/immunisation with highly adaptable carriers |
| 03/10/2010 | CN100593544C Mutants of the P4 protein of nontypable haemophilus influenzae with reduced enzymatic activity |
| 03/10/2010 | CN100593419C Methods and compositions for controlling ectoparasites |
| 03/10/2010 | CN100593418C Spray for treating burn |
| 03/09/2010 | US7674895 Compositions and methods for siRNA inhibition of angiogenesis |
| 03/09/2010 | US7674890 stimulating gastrointestinal epithelial cell proliferation, patient suffering from degeneration, mucositis, inflammatory bowel disease, or undergoing cancer treatment, or restore the digestive and absorptive processes following surgical resection of the intestine; bioassay; polynucleotide gene therapy |
| 03/09/2010 | US7674889 makes it possible to detect the expression of the same in various tissues, analyze their structures and functions, and produce the human proteins encoded by the genes by genetic engineering; hereditary diseases and cancer |
| 03/09/2010 | US7674888 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes |
| 03/09/2010 | US7674887 3'-{N'-[1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-2'-hydroxybiphenyl-3-carboxylic acid; thrombocytopenia and megakaryocytopoiesis treatment |
| 03/09/2010 | US7674882 biocompatible polymer is blended with silk protein prior to processing; electrospinning; avoids use of organic solvents and problems associated with conformational transitions of fibroin during solubilization and reprocessing from aqueous solution which lead to embrittled materials |
| 03/09/2010 | US7674880 Anthrax and small pox replikins and methods of use |
| 03/09/2010 | US7674777 Immunostimulatory nucleic acid molecules |
| 03/09/2010 | US7674775 4-(N (S-glutathionylacetyl)amino)phenylarsenoxide (GSAO) and derivatives; antiinflammatory and antitumor agents; blood and autoimmune disorders; viral infections; anticoagulants |
| 03/09/2010 | US7674774 Abuse-resistant amphetamine prodrugs |
| 03/09/2010 | US7674773 Glycosylated derivative of hypolipemic agents; side effect reduction; therapy for insulin resistance; hyperlipidemia agent; impaired lipid metabolism; lowering cholesterol levels |
| 03/09/2010 | US7674772 Compositions and methods for treating atherosclerosis |
| 03/09/2010 | US7674771 laminin binding site |
| 03/09/2010 | US7674770 Anti-tumor drug, medicament, composition, and use thereof |
| 03/09/2010 | US7674769 Treatment of severe pneumonia by administration of tissue factor pathway inhibitor (TFPI) |
| 03/09/2010 | US7674768 Processes for preparing eptifibatide |
| 03/09/2010 | US7674767 comprising 0.1-30 weight % complex of water-soluble drug and counter-ion substance in which charged water-soluble drug is bonded with counter-ion substance, 0.5-80 weight % lipid, 0.5-80 weight % polymer, and 1-80 weight % emulsifier; high gastrointestinal absorption rate; high drug entrapping rate |
| 03/09/2010 | US7674766 Mass spectrometry-based identification of proteins |
| 03/09/2010 | US7674752 Functional protein arrays |
| 03/09/2010 | US7674604 Using computer modeling to identify positions where cysteinal insertion will lock protein comprising integrin domain sequences into preferential configuration; directed protein evolution |
| 03/09/2010 | US7674591 Methods of using antibodies to human IL-13bc for inhibiting IL-13 binding |
| 03/09/2010 | US7674470 Comprises clostridial neurotoxin light chain domains; endopeptidases; vaccines; fusion proteins; for inhibiting exocytosis |
| 03/09/2010 | US7674464 Intracellular interleukin-1 receptor antagonists |
| 03/09/2010 | US7674463 Method of inhibiting angiogenesis by administration of a corticotropin releasing factor receptor 2 agonist |
| 03/09/2010 | US7674458 Lysyl oxidase-like 1 (LOXL1) and elastogenesis |
| 03/09/2010 | US7674455 treating a mammal having amyotrophic lateral sclerosis by transducing a motor neuron of the mammal with an insulin-like growth factor I (IGF-1) gene or a glial cell line-derived neurotrophic factor (GDNF) gene; neurodegenerative disorders |
| 03/09/2010 | US7674453 Tumor necrosis factor combined with interferon in demyelinating diseases |
| 03/09/2010 | US7674451 Cosmetic or pharmaceutical composition comprising peptides, uses and treatment processes |
| 03/09/2010 | CA2493509C Rationally designed polysaccharide lyases derived from chondroitinase b |
| 03/09/2010 | CA2472449C Pharmaceutical composition for oral use with improved absorption |
| 03/09/2010 | CA2420495C A novel cationic lipopolymer as biocompatible gene delivery agent |
| 03/09/2010 | CA2382464C High-affinity choline transporter |
| 03/09/2010 | CA2342960C G protein-coupled receptor antagonists |